Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vermeer

Showing results (311-320 of 1,766) with videos related to

Pageof 177
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|June 16, 1999
[Ultraviolet A-I phototherapy for skin diseases]M C Polderman, S Pavel, B J Vermeer, et al.
Biochimica Et Biophysica Acta|February 11, 1997
Nutritional vitamin K-intake and urinary gamma-carboxyglutamate excretion in the ratA M Craciun, M M Groenen-van Dooren, C Vermeer
Nederlands Tijdschrift Voor Geneeskunde|August 3, 1996
[Terbinafine versus miconazole in patients with tinea pedis]B J Vermeer, C C Staats, J C van Houwelingen
The Plant Journal : for Cell and Molecular Biology|June 9, 2009
Heat stress activates phospholipase D and triggers PIP accumulation at the plasma membrane and nucleusMichael Mishkind, Joop E M Vermeer, Essam Darwish, et al.
Acta Paedopsychiatrica|January 1, 1992
Social inhibition and motor skill performance in first, third and fifth grade childrenJ H van Rossum, S van den Born, A Vermeer
Annals of the New York Academy of Sciences|May 4, 1992
Molecular cloning of the rat CD5 geneL Vermeer, N Bos, F Kroese, et al.
International Journal of Obesity (2005)|July 19, 2014
Small, medium, large or supersize? The development and evaluation of interventions targeted at portion sizeW M Vermeer, I H M Steenhuis, M P Poelman
FEBS Letters|October 5, 1987
Vitamin K-dependent carboxylase. Possible role for thioredoxin in the reduction of vitamin K metabolites in liverL Johan, M van Haarlem, B A Soute, et al.
Brain Research|August 11, 2012
Catechol and aldehyde moieties of 3,4-dihydroxyphenylacetaldehyde contribute to tyrosine hydroxylase inhibition and neurotoxicityLydia M M Vermeer, Virginia R Florang, Jonathan A Doorn
Molecular Therapy. Advances|May 15, 2026
Disease models and AAV therapies of <i>PKP2</i>-induced arrhythmogenic cardiomyopathyLotte Geerlings, Yago Rodriguez Carreras, Mathilde C S C Vermeer
Pageof 177

Showing results (311-320 of 1,766) with videos related to

Sort By:
Pageof 177
Nederlands Tijdschrift Voor Geneeskunde|June 16, 1999
[Ultraviolet A-I phototherapy for skin diseases]M C Polderman, S Pavel, B J Vermeer, et al.
Biochimica Et Biophysica Acta|February 11, 1997
Nutritional vitamin K-intake and urinary gamma-carboxyglutamate excretion in the ratA M Craciun, M M Groenen-van Dooren, C Vermeer
Nederlands Tijdschrift Voor Geneeskunde|August 3, 1996
[Terbinafine versus miconazole in patients with tinea pedis]B J Vermeer, C C Staats, J C van Houwelingen
The Plant Journal : for Cell and Molecular Biology|June 9, 2009
Heat stress activates phospholipase D and triggers PIP accumulation at the plasma membrane and nucleusMichael Mishkind, Joop E M Vermeer, Essam Darwish, et al.
Acta Paedopsychiatrica|January 1, 1992
Social inhibition and motor skill performance in first, third and fifth grade childrenJ H van Rossum, S van den Born, A Vermeer
Annals of the New York Academy of Sciences|May 4, 1992
Molecular cloning of the rat CD5 geneL Vermeer, N Bos, F Kroese, et al.
International Journal of Obesity (2005)|July 19, 2014
Small, medium, large or supersize? The development and evaluation of interventions targeted at portion sizeW M Vermeer, I H M Steenhuis, M P Poelman
FEBS Letters|October 5, 1987
Vitamin K-dependent carboxylase. Possible role for thioredoxin in the reduction of vitamin K metabolites in liverL Johan, M van Haarlem, B A Soute, et al.
Brain Research|August 11, 2012
Catechol and aldehyde moieties of 3,4-dihydroxyphenylacetaldehyde contribute to tyrosine hydroxylase inhibition and neurotoxicityLydia M M Vermeer, Virginia R Florang, Jonathan A Doorn
Molecular Therapy. Advances|May 15, 2026
Disease models and AAV therapies of <i>PKP2</i>-induced arrhythmogenic cardiomyopathyLotte Geerlings, Yago Rodriguez Carreras, Mathilde C S C Vermeer
Pageof 177